ESSA Pharma Inc. (EPIX) Short-Term Debt to Equity

Graphic logo of ESSA Pharma Inc. (EPIX)

ESSA Pharma Inc. (EPIX) develops selective inhibitors to combat tumors, leveraging a debt-free balance sheet and a liquid cash reserve. However, the failure of key trials has escalated threats to a critical stage, and the current indicator stands at 0.00. This share price chart clearly illustrates the current situation. Meanwhile, the development of life-saving drugs remains a non-cyclical activity, where success depends on science rather than market fluctuations.

EPIX - ESSA Pharma Inc. Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/25/2025

Financial and market metric breakdowns for ESSA Pharma Inc (EPIX)

- stock quotes and analyst forecast:
Stock Price ESSA Pharma Inc.|EPIX - Analyst Consensus Forecast
- market capitalization details:
Market Value ESSA Pharma, Inc.|EPIX - Business Value
- balance sheet equity data:
Book Value per Share ESSA Pharma|EPIX - Company Net Assets|Market Capitalization to Book Value Ratio essapharma.com|EPIX - Company Assets
- business debt structure and liquidity details:
Debt to Equity ESSA Pharma Inc.|EPIX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio ESSA Pharma Inc.|EPIX - Aggregate Debt Obligations|Debt to Book Value ESSA Pharma, Inc.|EPIX - Company Long-Term Liabilities|Company Short-Term Debt ESSA Pharma
Fundamental valuation:ESSA Pharma EPIX
Signature product of essapharma.com

Developing innovative prostate cancer treatments requires significant investment, making the monitoring of short-term liabilities relative to equity critical for assessing the solvency of ESSA Pharma Inc. (EPIX). By analyzing the short-term debt-to-equity trend, an investor can determine the risk of cash flow gaps: excessive debt load signals financial instability, while a deficit indicates inefficient resource utilization.

Competitors of ESSA Pharma Inc.

Short-Term Debt to Capital MRUS|Short-Term Debt to Capital Immutep Corp (IMMP)|Short-Term Debt to Equity Anixa Biosciences, Inc. ANIX|ATOS: Short-Term Debt to Capital Ratio|Context Tx - Short-Term Debt to Capital|Mersana Therapeutics (MRSN) - Short-Term Debt to Equity Ratio|BCTX: Short-Term Debt to Capital|Current Liabilities to Capital QT Imaging, Inc. (QTI)